Related by context. All words. (Click for frequent words.) 68 Li Fraumeni syndrome 68 MSH2 68 somatic mutations 68 germline mutations 67 LRRK2 gene 67 basal cell nevus syndrome 66 KRAS oncogene 66 genes predisposing 66 Brugada syndrome 66 susceptibility gene 66 neuroblastoma tumors 65 p# mutation 65 mutated genes 65 mutated K ras 65 PTEN gene 65 BRCA1 BRCA2 65 fronto temporal dementia 65 PTPN# 65 BRAF gene 65 C#Y 65 MYH9 gene 65 ADPKD 65 causative genes 64 mutations 64 CDH1 64 BRAF V#E 64 Epstein Barr virus EBV 64 nonhereditary 64 APOE4 64 p# mutations 64 inherited mutations 64 K ras mutations 64 Li Fraumeni 64 CCR5 delta# 64 chromosomal aberrations 64 recessive trait 64 dyskeratosis congenita 64 familial adenomatous polyposis 64 Fragile X gene 64 missense mutations 64 CC genotype 63 mutated BRCA1 63 monogenic 63 mtDNA mutations 63 TP# mutations 63 HLA DQ2 63 TCF#L# gene 63 MC1R gene 63 hypermethylated 63 GISTs 63 BRCA1 mutations 63 androgen receptor gene 63 mitochondrial mutations 63 MTHFR 63 TP# gene 63 heterozygotes 63 HNPCC 63 familial pancreatic cancer 63 epigenetic changes 63 paraganglioma 63 breast cancer genes BRCA1 63 MLH1 63 GBM tumors 63 epigenetically 63 IDH1 mutations 63 mutation 63 familial ALS 63 mutated gene 63 prostate carcinoma 63 cisplatin resistant 63 allelic variants 63 GBA mutations 63 hereditary predisposition 63 lung adenocarcinoma 63 Leukemias 63 activating mutation 63 Hurthle cell 63 FMR1 gene 63 de novo mutations 63 VHL gene 62 Hashimoto thyroiditis 62 MLL2 62 sporadic ALS 62 ApoE4 gene 62 SOD1 gene 62 NF1 gene 62 benign polyps 62 genetic alteration 62 PALB2 62 LRAT 62 immunocompetent 62 familial adenomatous polyposis FAP 62 autosomal recessive 62 missense mutation 62 microdeletions 62 IgA deficiency 62 BRCA2 gene 62 normal karyotype 62 Lafora disease 62 MEF2A 62 Metastases 62 autosomal dominant polycystic kidney 62 SCN1A 62 CYP#A# gene 62 GIST tumors 62 CDKN2A 62 CYP#D# gene 62 ApoE4 62 chromosomal deletions 62 hamartomas 62 Papillary 62 epigenetic silencing 62 transgenic mouse models 62 molecular abnormalities 62 von Hippel Lindau 62 IKZF1 62 heterozygous 62 gene BRCA2 62 GSTM1 gene 62 seminomas 62 Neurofibromatosis type 61 spontaneous mutation 61 gene APOE4 61 cardiac channelopathies 61 Basal Cell 61 Wwox 61 genomic alterations 61 proband 61 ataxias 61 Kufs disease 61 intestinal polyps 61 metaplasia 61 ABCB1 61 nondemented 61 PTEN mutations 61 MGUS 61 LQTS 61 LRRK2 mutation 61 ovarian endometrial 61 mutant genes 61 radiosensitive 61 sCJD 61 TGFBR1 * 6A 61 deleterious mutations 61 prostate adenocarcinoma 61 genomic rearrangements 61 Germline 61 PNET 61 #q#.# [001] 61 narcolepsy cataplexy 61 mitochondrial proteins 61 JAK mutations 61 apoE4 61 adenomatous polyps 61 ALK gene 61 spontaneous mutations 61 mutant allele 61 leiomyomas 61 FASPS 61 LRRK2 mutations 61 nutlin 3a 61 TACI mutations 61 gene rearrangements 61 Leydig cell 61 oncogenic mutations 61 chromosomal rearrangement 61 syngeneic 61 pathogenic mutations 61 FGFR2 61 MYCN amplification 61 BARD1 61 dominantly inherited 61 miRNA genes 61 autosomal dominant disorder 61 mesotheliomas 61 GSTP1 61 neurofibromas 61 curable cancers 61 APOE ε4 61 HFE gene 61 Helicobacter 61 Genetic mutations 61 K#N 61 epigenetic modifications 61 OGG1 61 apolipoprotein E gene 61 genetic mutation 61 APOL1 60 microcephalin 60 herpesviruses 60 chromosomal mutations 60 MMP# 60 germline mutation 60 GSTM1 60 abnormal chromosomes 60 HIV HCV coinfected 60 BRCA mutation 60 benign moles 60 BRCA1 gene 60 Tumours 60 motor neuron degeneration 60 prostate cancer CaP 60 hyperplastic 60 monozygotic twin 60 LMNA 60 aneuploidies 60 cancerous polyps 60 overt hypothyroidism 60 Hypophosphatasia 60 CHD5 60 Estrogen Receptor 60 lymph node biopsies 60 TTR gene 60 Clusterin 60 renal carcinoma 60 homozygotes 60 abnormal proteins 60 renal cell carcinomas 60 genes BRCA1 60 cryptogenic 60 angiosarcoma 60 HNSCC 60 progressive neurodegenerative disorder 60 unmutated 60 gastrointestinal stromal tumors GISTs 60 MC1R 60 T1DM 60 Chronic pancreatitis 60 SMN1 60 nonalcoholic steatohepatitis NASH 60 liver metastasis 60 Vitamin B# deficiency 60 inherited predisposition 60 genetic variant 60 mitochondrial DNA mutations 60 NF1 60 genetic polymorphisms 60 susceptibility alleles 60 colorectal carcinoma 60 BRCA2 gene mutation 60 beta1 integrin 60 BDNF gene 60 HLA genes 60 micrometastases 60 dysgenesis 60 gastric carcinomas 60 pathological hallmark 60 MeCP2 gene 60 LHRH receptor positive 60 proto oncogene 60 non coding RNA 60 modifier genes 60 systemic amyloidosis 60 COL#A# 60 causative gene 60 nonmelanoma skin cancers 60 klotho 60 pancreatic adenocarcinoma 60 progerin 60 genetic determinants 60 granulosa cell 60 MTHFR gene 60 CREBBP 60 Fibroblasts 60 APOE e4 60 MECP2 gene 60 GSTT1 60 Beta thalassemia 60 LRP5 60 gene locus 60 K ras gene 60 DICER1 60 genetic mutations 60 recessive mutations 60 BRCA deficient 60 bronchoalveolar 60 Ets2 60 endostatin 60 C1q 60 neoplastic 60 mosaicism 60 chromosomal alterations 60 GPC5 60 synovial cells 60 maternally inherited 60 breast cancer subtypes 60 tumor suppressor protein 59 immunodeficient 59 parkin gene 59 familial hypercholesterolemia 59 commonly mutated genes 59 carcinoid tumor 59 gene polymorphism 59 G#S mutation 59 alpha synuclein gene 59 Asymptomatic 59 Genetic variants 59 neurofibroma 59 JAK2 enzyme 59 peritoneal carcinomatosis 59 colorectal adenoma 59 nodal metastasis 59 histone deacetylases 59 untreated celiac disease 59 IDH1 mutation 59 alleles 59 PTEN tumor suppressor 59 HLA DRB1 59 BRAF mutation 59 SCN5A 59 T1D 59 bladder tumors 59 epigenetic mechanisms 59 Cysts 59 UGT#A# * 59 Hutchinson Gilford progeria 59 circadian genes 59 ORMDL3 59 BRAF V#E mutation 59 KRAS mutations 59 SHANK3 59 DLC1 59 neuroblastomas 59 Heterozygous 59 CHEK2 59 Cockayne syndrome 59 Adjuvant chemotherapy 59 genetic abnormality 59 progranulin mutations 59 lichen planus 59 acute lymphoblastic 59 epithelial tissues 59 endogenous retroviruses 59 mutant gene 59 hypokalemia hypomagnesemia 59 supratentorial 59 nonischemic 59 IDH mutations 59 inherited genetic mutation 59 CDK4 59 epithelial barrier 59 chronic myeloid 59 ApoE 59 oxysterols 59 JAK2 mutation 59 precancer 59 EoE 59 mitochondrial DNA mtDNA 59 invasive lobular 59 adenoma 59 gene predisposing 59 papillary renal cell carcinoma 59 Genetic Variation 59 keloid scars 59 mutated protein 59 globin 59 mammary cells 59 KIF6 gene 59 APOE genotype 59 melanocytic nevi 59 HLA B# 59 T#I [002] 59 A. fumigatus 59 heterotaxy 59 genetic loci 59 Leydig cells 59 PALB2 gene 59 Rh factor 59 polycystic kidneys 59 hereditary hemochromatosis 59 pleural mesothelioma 59 Loeys Dietz syndrome 59 underlying pathophysiology 59 haemochromatosis 59 atypical hyperplasia 59 susceptibility locus 59 APOE e4 gene 59 aneuploid cells 59 Immunohistochemical analysis 59 tau protein tangles 59 Brugada Syndrome 59 cranial irradiation 59 klotho gene 59 suppressor gene 59 BRIP1 59 promoter hypermethylation 59 FXTAS 59 K#R [002] 59 genes BRCA 59 Predisposition 59 atypical neuroleptics 59 KRAS mutation 59 seminoma 59 gene mutation 59 deleterious mutation 59 diagnostic biomarker 59 Arrhythmogenic 59 Glioblastoma Multiforme GBM 59 SOD2 gene 59 morphogen 59 BRCA breast cancer 59 PIK3CA 59 histologic subtype 59 bronchogenic carcinoma 59 CSF biomarkers 59 nonmetastatic 59 amyloid deposits 59 autoantibodies 59 CFTR gene 59 relapsed ALL 59 susceptibility loci 59 carcinoids 59 null mice 59 chromosomal anomalies 59 genetic polymorphism 59 chronic granulomatous disease 59 autosomal recessive disease 59 anaplastic 59 malignant transformation 59 SSc 59 FGFR2 gene 59 myopathies 59 Basal cell 59 SORL1 gene 58 brain lesions 58 Haptoglobin 58 vivax 58 NAT2 58 subclinical hyperthyroidism 58 spontaneous remission 58 hypermethylation 58 Dr. Bezprozvanny 58 phenothiazines 58 motor neuron diseases 58 precancerous condition 58 amyloid deposition 58 PTLD 58 TEL AML1 58 5 HTT gene 58 GLUT1 58 NMIBC 58 HbF 58 idiopathic myelofibrosis 58 TTR amyloidosis 58 unresectable tumors 58 Sjögren syndrome 58 telomere lengths 58 COX2 58 Male pattern baldness 58 pituitary adenomas 58 genetic variants associated 58 urothelial cancer 58 intracellular bacteria 58 ERBB2 58 biochemical abnormalities 58 APOE4 gene 58 cysteines 58 irradiated mice 58 primary hyperparathyroidism 58 vWD 58 homozygous 58 frontotemporal dementia 58 laforin 58 NFTs 58 gastric atrophy 58 leptin deficiency 58 potent inducer 58 HGPS 58 BRCA mutations 58 APOE gene 58 TOP2A gene 58 inherit predisposition 58 metastatic lymph nodes 58 aneuploid 58 CHD7 58 Trichophyton rubrum 58 pancreatic endocrine 58 FTLD 58 autosomal dominant 58 LKB1 58 senescent cells 58 MIF protein 58 transgenic rats 58 fibrous tangles 58 Carcinoid tumors 58 colorectal polyps 58 neoplastic cells 58 ependymomas 58 Autoantibodies 58 GNAQ 58 CAG repeats 58 PPARγ 58 autoimmune pancreatitis 58 Gene Mutation 58 huntingtin gene 58 NKX2 58 EGFR mutation 58 serous ovarian cancer 58 Klotho gene 58 neoplasias 58 Meckel Gruber 58 distinct subtypes 58 Dpp 58 TGFBR1 58 apolipoprotein E4 58 pDCs 58 chromosome #q# [001] 58 lymphocytic 58 promoter methylation 58 RET PTC rearrangements 58 astrocytomas 58 Epidermal Growth Factor Receptor 58 TOMM# 58 extramedullary 58 homozygous FH 58 breast carcinomas 58 hormone receptor negative 58 homozygosity 58 HLA molecules 58 genetic aberrations 58 incurable genetic 58 prostate cancer PCa 58 leukaemic cells 58 Homozygous 58 PON1 58 TMEM#B 58 idiopathic PAH 58 metabolic abnormalities 58 CALHM1 58 NR#A# 58 Genetic mutation 58 Prox1 58 gene variant 58 DNA rearrangements 58 ductal breast cancer 58 breast cancer metastasis 58 holoprosencephaly 58 CYP#C# [001] 58 operable breast cancer 58 sarcoid 58 budding yeast 58 activating mutations 58 Genetic variation 58 Epstein Barr Virus 58 cAMP signaling 58 transfusion syndrome 58 BRCA2 carriers 58 homozygote 58 hamartoma 58 insulin secreting beta 58 acinar cells 58 BMPR2 58 genetic syndromes 58 V Leiden 58 sporadic Creutzfeldt Jakob 58 Endometrial 58 Uterine cancer 58 autosomal recessive disorder 58 differential gene expression 58 advanced neoplasia 58 SNP rs# [001] 58 pre malignant lesions 58 primordial germ cells 58 EGFR gene 58 teratoma 58 microdeletion 58 granzyme B 58 precursor lesions 58 SLC#A# [002] 58 cyclin E 58 mutant worms 58 recessive mutation 58 defective gene 58 lung adenocarcinomas 58 FGFR1 58 basal cell carcinoma BCC 58 amyloid β peptide 58 ZNF# 58 pretransplant 58 UVB induced 58 TET2 58 immunized mice 58 EBV infection 58 inherited retinal degeneration 58 achromatopsia 58 euthymic patients 58 pulmonary metastasis 58 familial clustering 58 mice lacking 58 molecular subtypes 58 neurocognitive impairment 58 testicular germ cell 58 RRM1 58 TPMT 58 squamous cell lung cancer 58 predisposing factor 58 Fibroblast 58 etiologic factors 58 resistant isolates 58 cytogenetic abnormalities 58 mitogen activated protein kinases 58 androgen receptor AR 58 Dr. Loeken 58 malignant pleural mesothelioma 58 lymphoid cells 58 chromosome abnormality 58 alveolar rhabdomyosarcoma 58 methylation patterns 58 shorter telomeres 58 promyelocytic leukemia 58 filaggrin 58 Squamous 58 Chronic lymphocytic leukemia 58 myeloproliferative neoplasms 58 microfilariae 58 microvascular disease 57 chromosome #p# [001] 57 varicocele 57 alpha1 antitrypsin deficiency 57 thrombophilia 57 LIS1 57 congenital deficiency 57 melanocyte stimulating hormone 57 COMT gene 57 protein encoded 57 pancreatic tissue 57 castration resistant 57 R#W [002] 57 C. neoformans 57 breast endometrial 57 Akt1 57 DNA adducts 57 apo E 57 PCNSL 57 hepatocellular carcinomas 57 abnormal hemoglobin 57 cell carcinomas 57 SCD1 57 haematopoietic 57 progranulin gene 57 ARVD 57 autoimmune thyroiditis 57 MAP#K# 57 gastric carcinoma 57 lysosomal storage disease 57 papillary carcinoma 57 prion infection 57 CYP#C# gene 57 microglial 57 C EBP alpha 57 noncoding RNAs 57 Dwarfism 57 acinar 57 fatal neuromuscular disorder 57 mutated BRCA 57 Gleevec resistant 57 gene deletions 57 WT1 57 mycosis fungoides 57 abnormal glucose metabolism 57 pleomorphic 57 KCNQ1 57 FUS1 57 hair follicle stem cells 57 glutamic acid decarboxylase 57 radiolabeled antibodies 57 KIT mutations 57 LHON 57 Smad3 57 hydrops 57 telomere shortening 57 osteosarcomas 57 Single Nucleotide Polymorphisms SNPs 57 tumor histology 57 Prostatitis 57 RUNX3 57 colon tumors 57 virulence genes 57 AGTR1 57 KIBRA 57 regulator CFTR gene 57 SOD1 mutation 57 HLA DR 57 varicoceles 57 T2DM 57 PCa 57 Glioma 57 PrPSc 57 FLT3 57 hypertrophic cardiomyopathy HCM 57 autopsied brains 57 miRNA expression 57 metastatic gastric 57 #q# [002] 57 epigenetic regulation 57 Cryptococcus neoformans 57 ALK inhibitors 57 MC4R gene 57 xeroderma pigmentosum 57 NFKBIA 57 G#S [002] 57 nucleoli 57 grade serous ovarian 57 circadian clock genes 57 Francisella 57 dopamine receptor gene 57 debilitating neurodegenerative disorder 57 Tay Sachs thalassemia 57 Epstein Barr 57 #p# [001] 57 EGFR mutations 57 BRCA gene mutation 57 HLA DRB1 * 57 chemoresistant 57 #q# deletion 57 downregulated 57 Squamous Cell 57 polycystic ovarian syndrome PCOS 57 APOC3 57 Acute myeloid leukemia 57 autoinflammatory 57 spontaneously regress 57 Glioblastoma multiforme GBM 57 histopathologic examination 57 mucinous 57 SLC#A# gene [001] 57 poorer prognosis 57 Chlamydia pneumoniae 57 karyotypes 57 chromosome translocations 57 Aβ# 57 vimentin 57 apoE 57 G6PD deficiency 57 Lymph node 57 familial dysautonomia 57 micro RNAs 57 allele frequencies 57 telomeres shorten 57 DICER1 gene 57 thyroid nodules 57 diabetes mellitus DM 57 gene mutations 57 prion gene 57 LDLR 57 WDR# 57 ADAMTS# 57 alpha thalassemia 57 malignant phenotype 57 premalignant 57 endometrial cancers 57 mammary stem cells 57 Premature Aging 57 V#F mutation 57 ApoE gene 57 penetrance 57 Karlseder 57 TRIM5a 57 coding exons 57 MAPK pathway 57 methylenetetrahydrofolate reductase 57 Activating mutations 57 NEIL1 57 multidrug resistance 57 heterozygote 57 epigenetic modification 57 thyroiditis 57 gene APOE 57 Mitochondrial 57 breast epithelial cells 57 β amyloid 57 colorectal neoplasms 57 monocytic 57 susceptibility genes 57 DLX5 57 β thalassemia 57 pyruvate kinase 57 stage IIIA 57 serine protease 57 myeloproliferative 57 TCF#L# 57 progressive neurodegenerative 57 epigenetic alterations 57 hematopoietic cells 57 pituitary tumors 57 ductal carcinomas 57 hepatoma 57 metastatic tumors 57 phenotype 57 precancerous polyp 57 chromosome aberrations 57 AAT deficiency 57 galactosemia 57 flavopiridol 57 B7 H3 57 presymptomatic 57 recessive genetic 57 Alport syndrome 57 SORL1 57 #S rRNA 57 paraneoplastic 57 type2 diabetes 57 chromosome rearrangements 57 Peutz Jeghers syndrome 57 hypogonadotropic hypogonadism 57 receptor gene 57 haplotypes 57 trophoblasts 57 bladder carcinoma 57 nestin 57 DNA methylation patterns 57 Myotonic dystrophy 57 apolipoprotein E APOE 57 thymoma 57 Hp2 2 57 Dystrophin 57 premalignant lesions 57 HER2 expression 57 p# activation 57 trophoblast cells 57 pulmonary metastases 57 Nodules 57 #p# [003] 57 epigenetic markers 57 IL #R 57 myotonic dystrophy 57 breast carcinoma 57 apolipoprotein E 57 adenomatous 57 Endometrial cancer 57 xenograft tumors 57 Hyperthyroidism 57 gene polymorphisms 57 vestibular schwannomas 57 gene amplification 57 CIB1 57 elevated CRP 57 amyloid beta plaques 57 polymorphic ventricular tachycardia 57 Rectal cancer 57 shortened telomeres 57 TSC1 57 genetic locus 57 androgen deprivation 57 MCAD deficiency 57 Froguel 57 spongiform encephalopathies 57 KCNH2 57 protein p# 57 SMN protein 57 Apolipoprotein E 57 calculi 57 immunohistochemical analysis 57 TOP2A 57 fruitfly Drosophila 57 H pylori 57 BRAC2 57 herpes simplex encephalitis 57 advanced adenomas 57 Cyclin E 57 acute myeloid 57 CYT# potent vascular disrupting 57 EGFR protein 57 alpha synuclein protein 57 monoclonal gammopathy 57 Subtypes 57 papillomas 57 FGFR4 57 Cholangiocarcinoma 57 constitutively expressed 57 aldehyde dehydrogenase 57 prognostic indicator 57 homodimers 57 mutated p# 57 cervical lymph nodes 57 DSBs 56 melanocyte 56 Rad# 56 PARP inhibition 56 SIRT6 56 idiopathic pulmonary 56 genomic instability 56 NPC1 56 BRCA2 mutations 56 Genes Identified 56 TNF blocker therapy 56 transgenic mouse model 56 primary cilia 56 Telomere length 56 Infectivity 56 Mutational 56 prognostic marker 56 CYP#D# 56 Notch1 56 postoperative delirium 56 LRP6 56 methylation markers 56 IGFBP2 56 SMN2 gene 56 Epstein Barr Virus EBV 56 Sox9 56 chitinase 56 vesicular stomatitis virus 56 N. gonorrhoeae 56 NKT cells 56 IRS1 56 Recurrences 56 advanced adenoma 56 polymyalgia rheumatica 56 sickle cell cystic fibrosis 56 HER2 overexpression 56 pyrimidines 56 faulty BRCA2 gene 56 HG PIN 56 Alleles 56 ERCC1 56 hyperinsulinemic 56 MELAS 56 pre cancerous lesion 56 cancerous polyp 56 leiomyoma 56 transthyretin 56 gynecologic malignancy 56 highly heritable 56 PKCi 56 urothelial carcinoma 56 tumor subtypes 56 IDDM 56 selenium deficient 56 mammary cancers 56 mutant KRAS 56 Pulmonary hypertension 56 non mutated KRAS 56 generalized vitiligo 56 pulmonary hypertension PH 56 cyclophilin D 56 mitochondrial disorders 56 preeclamptic 56 abnormal growths 56 epithelioid 56 Oncogenic 56 tumor suppressor gene 56 penicillin allergy 56 TT genotype 56 HMGA2 56 polyps growths 56 infecting organism 56 Thyroid disorders 56 Mycoplasma pneumoniae 56 paralogs 56 causative mutations 56 BRAF mutations 56 defensin 56 Neural stem cells 56 malignant prostate 56 Six3 56 N Myc 56 anemias 56 Philadelphia Chromosome Positive 56 Crizotinib 56 colon carcinoma 56 nephrosis 56 RNA ribonucleic acid 56 inducible nitric oxide synthase 56 colonic polyps 56 FUS protein 56 CCR5 mutation 56 Alu elements 56 hippocampal cells 56 low ptau levels 56 malignant lymphoma 56 papillary RCC 56 hematopoietic cancers 56 Pten 56 neuritic 56 SOD1 protein 56 pheochromocytomas 56 myelofibrosis polycythemia vera 56 BRCA1 mutation 56 hyperactivation 56 CpG island 56 DHFR 56 IDH1 56 herpes viruses 56 channelopathies 56 replicase 56 CXCL5 56 Histologically 56 NSCLC tumors 56 mutant proteins 56 ras gene 56 Skp2 56 PECAM 1 56 rifamycins 56 IGF2 56 thyroid carcinoma 56 sickle hemoglobin 56 globin genes 56 KLF4